OpenVSafe by OpenVAERS
Search V-safe

ZLL-26940-32135

1 vaccination 1 coded response 5 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
666 / KS
Registered
2021-04-02
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-02
    Registered in v-safe
  3. 2021-04-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness, Nausea
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-02

Systemic reaction (other): Dizziness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release